etidronate has been researched along with Hyperparathyroidism, Secondary in 5 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with menatetrenone, risedronate or regular sunlight exposure are safe and effective in increasing bone mass and reducing the risk of hip fracture in patients with AD." | 2.46 | [Dementia and fracture]. ( Sato, Y, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, Y | 1 |
| Torregrosa, JV | 1 |
| Durán, CE | 1 |
| Barros, X | 1 |
| Blasco, M | 1 |
| Arias, M | 1 |
| Cases, A | 1 |
| Campistol, JM | 1 |
| Hoppé, E | 1 |
| Masson, C | 1 |
| Laffitte, A | 1 |
| Chappard, D | 1 |
| Audran, M | 1 |
| Fujita, T | 1 |
| Orimo, H | 1 |
| Inoue, T | 1 |
| Kaneda, K | 1 |
| Sakurai, M | 1 |
| Morita, R | 1 |
| Yamamoto, K | 1 |
| Sugioka, Y | 1 |
| Inoue, A | 1 |
| Takaoka, K | 1 |
| Yamamoto, I | 1 |
| Hoshino, Y | 1 |
| Kawaguchi, H | 1 |
| Creutzig, H | 1 |
1 review available for etidronate and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
[Dementia and fracture].
Topics: Accidental Falls; Bone Density; Dementia; Etidronic Acid; Hip Fractures; Humans; Hyperparathyroidism | 2010 |
2 trials available for etidronate and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.
Topics: Aged; Alendronate; Alkaline Phosphatase; Arterioles; Calciphylaxis; Calcium; Comorbidity; Diphosphon | 2012 |
Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Creatinine; Double-Blind Method; | 2007 |
2 other studies available for etidronate and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
Topics: Aged, 80 and over; Alkaline Phosphatase; Biopsy; Bone Density Conservation Agents; Calcification, Ph | 2012 |
[A comparison of osteotropic radiopharmaceuticals. II. Plasma clearance of 18F and 99mTc-EHDP (author's transl)].
Topics: Bone and Bones; Bone Diseases; Chromium; Chromium Radioisotopes; Creatinine; Edetic Acid; Etidronic | 1975 |